ASIAPAC FIN INV (08193) released its annual performance results, with shareholders' share of profit amounting to 36.609 million Hong Kong dollars, turning a loss into a profit year-on-year.
Asia Pacific Financial Investment (08193) released its annual performance as of March 31, 2026. The group achieved a total revenue of HK$30.174 million, a decrease of 0.31% year-on-year. The company's net profit attributable to owners was HK$36.609 million, compared to a loss of HK$8.765 million in the same period last year. Earnings per share were 13.08 HK cents.
ASIAPAC FIN INV (08193) released its annual performance for the year ending on March 31, 2026. The group achieved a total revenue of HK$301.74 million, a decrease of 0.31% year-on-year. The profit attributable to company owners was HK$366.09 million, compared to a loss of HK$87.65 million in the same period last year. Earnings per share were HK$0.1308.
Related Articles
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) rose more than 4%, with the amount of stock repurchase exceeding 1.99 billion RMB so far this year.
AI computing power demand continues to be hot! Amazon.com, Inc. (AMZN.US) Cloud computing business AWS once again raised GPU capacity reservation service prices.
Lebang Pharmaceutical-B (09637) public offering received nearly a thousand times oversubscribed and will debut on the Hong Kong Stock Exchange on June 29.
US Stock Market Move | Kanzhun Ltd. Sponsored ADR (BZ.US) rose more than 4%, with the amount of stock repurchase exceeding 1.99 billion RMB so far this year.
AI computing power demand continues to be hot! Amazon.com, Inc. (AMZN.US) Cloud computing business AWS once again raised GPU capacity reservation service prices.
Lebang Pharmaceutical-B (09637) public offering received nearly a thousand times oversubscribed and will debut on the Hong Kong Stock Exchange on June 29.
RECOMMEND
